{"id":1053057,"title":"DSEN Abstract: Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-26","captureTimestamp":"2026-04-26T03:15:09.673000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52735.html","snippet":"DSEN Abstract Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada In 2019, some batches of ranitidine, a readily available histamine H-2 receptor antagonist that counteracts stomach acid, contained an impurity called N-nitrosodimethylamine…","rawSnapshotUrl":"/api/snapshots/raw/1053057","browseUrl":"https://replay.healtharchive.ca/job-8/20260426031509/https://cihr-irsc.gc.ca/e/52735.html#ha_snapshot=1053057","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}